WHAT: Pfizer Oncology will host a journalist briefing at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, June 1, 2008, highlighting key data presentations from a variety of compounds in several difficult-to-treat tumor types, including renal cell carcinoma and non-small cell lung cancer. Leading oncology physicians and researchers will present study results and offer their professional perspective.
